110 related articles for article (PubMed ID: 481845)
21. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
Wile AG; Sparks FC; Morton DL
Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
[TBL] [Abstract][Full Text] [Related]
22. Treatment of disseminated malignant melanoma with high-dose oral BCG.
Varella AD; Bandiera DC; de Amorim AR; Calvis LA; Santos IO; Escaleira N; Gentil F
Cancer; 1981 Sep; 48(6):1353-62. PubMed ID: 7023654
[TBL] [Abstract][Full Text] [Related]
23. The use of oral BCG in the treatment or metastatic malignant melanoma.
Pritchard KI; Cowan DH; Baker MA; Osoba D; Phillips RA; Clark DA
Med Pediatr Oncol; 1976; 2(2):173-81. PubMed ID: 785199
[TBL] [Abstract][Full Text] [Related]
24. Effects of methanol extraction residue of Bacillus calmette-Guérin in humans.
Perloff M; Holland JF; Lumb GJ; Bekesi JG
Cancer Res; 1977 Apr; 37(4):1191-6. PubMed ID: 321117
[TBL] [Abstract][Full Text] [Related]
25. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy of melanoma.
Nathanson L
J Cutan Pathol; 1979 Jun; 6(3):213-26. PubMed ID: 383755
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of systemic BCG therapy in advanced melanoma.
El-Domeiri AA; Nika B; Hsia WC; Crispen R; Sabet TY; Gupta TK
Arch Surg; 1977 Mar; 112(3):257-9. PubMed ID: 843215
[TBL] [Abstract][Full Text] [Related]
28. [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas].
Saida T
Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1389-98. PubMed ID: 6984864
[No Abstract] [Full Text] [Related]
29. Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma.
Plesnicar S; Rudolf Z
Cancer; 1982 Sep; 50(6):1100-6. PubMed ID: 7104950
[TBL] [Abstract][Full Text] [Related]
30. Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma.
Shea CR; Imber MJ; Cropley TG; Cosimi AB; Sober AJ
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 2):1119-22. PubMed ID: 2681298
[TBL] [Abstract][Full Text] [Related]
31. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.
Storm FK; Sparks FC; Morton DL
Surg Gynecol Obstet; 1979 Jul; 149(1):17-21. PubMed ID: 451822
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant BCG immunotherapy for malignant melanoma.
Paterson AH; Willans DJ; Jerry LM; Hanson J; McPherson TA
Can Med Assoc J; 1984 Oct; 131(7):744-8. PubMed ID: 6383591
[TBL] [Abstract][Full Text] [Related]
33. Intralesional BCG in the treatment of metastatic malignant melanoma.
Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant immunotherapy in melanoma: a new approach.
Elias EG; Tomazic VJ; Buda BS
J Surg Oncol; 1992 Jul; 50(3):144-8. PubMed ID: 1619935
[TBL] [Abstract][Full Text] [Related]
35. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
36. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
37. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
39. Induction of cutaneous plasma cell tumor as a complication of adjuvant immunotherapy with methanol extraction residue of bacillus Calmette-Guérin.
Suster SM; Ronnen M; Huszar M; Pines A; Schibi-Brilliant G
Oncology; 1987; 44(5):279-82. PubMed ID: 3670794
[TBL] [Abstract][Full Text] [Related]
40. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma.
Nathanson L; Schoenfeld D; Regelson W; Colsky J; Mittelman A
Cancer; 1979 May; 43(5):1630-5. PubMed ID: 376098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
